FIELD: biotechnology.
SUBSTANCE: described is a group of inventions involving using as a vaccine a second antigenic composition which contains an effective amount of a mRNA construct encoding an immunogenic peptide or polypeptide, use as a vaccine of a first antigenic composition which contains an immunogenic peptide or polypeptide and/or which comprises a nucleic acid construct encoding an immunogenic peptide or polypeptide in an effective amount, wherein the first antigen composition is administered before administering the second antigen composition to the individual, using the first antigenic composition and the second antigen composition for vaccination, a combination of vaccines, a set of vaccines for inducing an immune response in an individual, a method for inducing an immune response in an individual.
EFFECT: invention extends the range of agents and methods for inducing an immune response in an individual.
194 cl, 3 dwg, 3 tbl, 4 ex
